Insmed (NasdaqGS:INSM) Q4 2025 Earnings call February 19, 2026 08:00 AM ET Company ParticipantsBryan Dunn - Head of Investor RelationsGraig Suvannavejh - Managing DirectorJason Zemansky - VPMartina Flammer - CMOSara Bonstein - CFOSteven Willey - Managing DirectorWill Lewis - Chair and CEOConference Call ParticipantsAdam Walsh - Managing Director and Senior Biotechnology Equity Research AnalystGavin Clark-Gartner - Managing Director and Biotechnology Equity Research AnalystJessica Fye - Managing Director and ...

Insmed (NasdaqGS:INSM) Q4 2025 Earnings call February 19, 2026 08:00 AM ET Speaker17Thank you for standing by, and welcome to the Insmed fourth quarter and full year 2025 financial results conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your ques ...

Ceragon Networks Ltd. Q4 2025 Earnings Call Summary - Moby Strategic Execution and Regional Performance Drivers Performance in Q4 2025 aligned with preliminary expectations, characterized by disciplined execution and a strengthened net cash position of $19.4 million. North American growth is sustained by solid Communication Service Provider (CSP) activity and a growing pipeline of private network opportunities. India operations have stabilized at a consistent run rate, with early 2026 bookings reinf ...

Core Insights - Myriad Genetics reported third-quarter revenue of $205.7 million, slightly above analyst estimates of $204.8 million, but experienced a 3.6% year-on-year decline [6] - Adjusted EPS was $0, beating analyst expectations of -$0.01, while adjusted EBITDA reached $10.3 million, significantly exceeding estimates of $5.57 million [6] - The company reaffirmed its full-year revenue guidance at $823 million and EBITDA guidance at $30 million, above analyst estimates of $27.52 million [6] Revenue and Profitability - The average revenue per test faced ongoing challenges, impacting overall market sentiment negatively despite meeting revenue expectations [1] - Operating margin decreased to -11.3%, down from -9.4% in the same quarter last year, indicating operational headwinds [6] Segment Performance - Strong volume growth was noted in the oncology segment, particularly for the MyRisk hereditary cancer test, which management views as a positive development [1] - The company faced pressures from reduced coverage for the GeneSight mental health test and a divested European business, but core test volumes showed signs of stabilization [1] Analyst Insights - Analysts raised questions regarding the balance between commercial investment and profitability, with management emphasizing an organizational redesign to support growth in cancer care while focusing on profit improvement [6] - Concerns were raised about the prenatal market share and operational improvements, with management addressing customer losses and future growth expectations from FirstGene [6] - Questions regarding hereditary cancer testing volume growth were clarified as stemming from improved customer workflows and EMR integration rather than a temporary rebound [6] Pricing and Market Dynamics - Average selling price declines in hereditary cancer tests were attributed to payer mix, biopharma revenue lumpiness, and changes in UnitedHealthcare's policy [6] - Plans to track an expanded provider base and multi-product adoption were highlighted as future key performance indicators [6] Operational Efficiency - Competitive turnaround times for Prequel and FirstGene tests were confirmed, with expectations for FirstGene to align with Prequel at launch [6]

Group 1 - The article emphasizes the importance of enabling Javascript and cookies in browsers to prevent access issues [1] - It highlights that users with ad-blockers may face restrictions when trying to access content [1]

Revenue Guidance - Topgolf raised its full-year revenue guidance [1] Industry Trend - Football fans spent extra time playing golf [1]

Group 1 - The article does not provide any relevant content regarding company or industry insights [1]

Core Insights - Matrix Service Company reported improved first-quarter results for fiscal 2026, driven by disciplined execution across its Storage & Terminal Solutions and Utility & Power Infrastructure segments [2][4] - The company has a robust opportunity pipeline of $6.7 billion and secured over $187 million in new awards during the quarter, indicating strong demand in the specialty engineering and construction sector [3][9] - The company reaffirmed its full-year revenue guidance, expecting revenue between $875 million and $925 million, representing a 14% to 20% increase compared to fiscal 2025 [19][20] Financial Summary - First-quarter fiscal 2026 revenue was $211.9 million, a 28% increase from $165.6 million in the same period of fiscal 2025 [5][9] - Gross margin improved to $14.2 million (6.7%) compared to $7.8 million (4.7%) in the prior year, attributed to better project execution and increased revenue volumes [6][9] - The company reported a net loss of $3.7 million ($0.13 per share), an improvement from a net loss of $9.2 million ($0.33 per share) in the first quarter of fiscal 2025 [8][9] Segment Performance - The Storage and Terminal Solutions segment saw revenue increase by 40% to $109.5 million, driven by higher work volumes for LNG storage and specialty vessel projects [10] - The Utility and Power Infrastructure segment's revenue rose by 33% to $74.5 million, benefiting from increased work in power delivery and natural gas projects [11] - The Process and Industrial Facilities segment experienced a revenue decline to $27.9 million, primarily due to lower volumes in thermal vacuum chamber projects [12] Backlog and Awards - The total backlog as of September 30, 2025, was $1.2 billion, with project awards totaling $187.8 million for the quarter, resulting in a book-to-bill ratio of 0.9x [13][9] - The Storage and Terminal Solutions segment had a book-to-bill ratio of 1.2x, indicating strong demand and project activity [13][9] Financial Position - As of September 30, 2025, the company had total liquidity of $248.9 million, with no outstanding debt [15][9] - The company reported a total of $192.3 million in unrestricted cash and cash equivalents [15] Guidance - The company reaffirmed its revenue guidance for fiscal year 2026, expecting revenue between $875 million and $925 million, reflecting a significant increase from the previous fiscal year [19][20]

Core Insights - Gentex Corporation's third-quarter 2025 adjusted earnings per share (EPS) of 46 cents missed the Zacks Consensus Estimate of 47 cents and decreased by 13.2% year over year [1][10] - The company reported net sales of $655.2 million, which lagged behind the Zacks Consensus Estimate of $674 million but represented an 8% increase from the previous year [2][10] Financial Performance - Gentex's gross margin improved to 34.4%, an increase of 90 basis points from the third quarter of 2024, attributed to reduced purchasing costs, improved product mix, and operational efficiencies [2] - Total operating expenses rose by 31.3% year over year to $102.84 million, with engineering and R&D expenses increasing to $52.63 million and SG&A expenses rising to $49.69 million [5] Segmental Performance - The Automotive segment's net sales totaled $558 million, down from $596.5 million in the year-ago quarter and below the estimate of $587.5 million, with total shipments declining by 8% to 11,246,000 units [3] - Other net sales, including dimmable aircraft windows and fire protection products, increased slightly from $12 million to $12.5 million [4] Shareholder Returns - Gentex paid a dividend of 12 cents per share and repurchased 1 million shares at an average price of $28.18 per share, with nearly 39.6 million shares authorized for repurchase as of September 30, 2025 [6] Guidance Update - The company revised its 2025 revenue guidance to a range of $2.5-$2.6 billion, up from the previous guidance of $2.44-$2.61 billion, reflecting the impact of the VOXX merger [7] - Sales from the primary market are now expected to be between $2.14-$2.15 billion, and sales from China are projected to be between $135-$145 million, an increase from earlier estimates [7][8]

Core Insights - Apogee Enterprises, Inc. (APOG) reported adjusted earnings per share (EPS) of 98 cents for Q2 fiscal 2026, exceeding the Zacks Consensus Estimate of 86 cents, but reflecting a 31.9% decrease from the prior-year quarter [1][10] - The company generated revenues of $358 million in the quarter, a 4.6% increase year-over-year, surpassing the Zacks Consensus Estimate of $334 million, driven by the acquisition of UW Solutions and higher Architectural Services volumes [2][10] - Apogee revised its fiscal 2026 guidance for net revenues to $1.39-$1.42 billion and adjusted EPS to $3.60-$3.90, down from previous estimates due to tariff headwinds and weaker margins [12] Financial Performance - Cost of sales increased by 12.4% year-over-year to $275.6 million, leading to a gross profit decline of 15.1% to $83 million, with gross margin decreasing to 23.1% from 28.4% [3] - Selling, general and administrative expenses rose by 0.7% to $56 million, while operating income fell by 35.9% to $27 million, resulting in an operating margin of 7.5% compared to 12.3% in the prior year [4] - Cash and cash equivalents stood at $39.5 million at the end of Q2 fiscal 2026, down from $41 million at the end of fiscal 2025, with cash provided by operating activities at $57.1 million [9] Segment Performance - Revenues in the Architectural Metals segment decreased by 0.3% year-over-year to $141 million, with adjusted EBITDA at $20.8 million [5] - Architectural Glass segment revenues fell by 19.9% to $72 million, with adjusted EBITDA around $12 million [6] - Performance Surfaces segment revenues surged by 144% to $48 million, with adjusted EBITDA increasing to $11.2 million [7] Backlog and Debt - The backlog for the Architectural Services segment increased to $792 million at the end of Q2 fiscal 2026, up from $682 million in the previous quarter [8] - Long-term debt decreased to $270 million at the end of Q2 fiscal 2026, down from $285 million at the end of fiscal 2025 [11] Stock Performance - Apogee's shares have declined by 45.1% over the past year, compared to a 25.8% decline in the industry [13]